Grupo de investigación en Adicciones a Sustancias
  • Quiénes somos
  • Investigación
  • Cohorte CohRTA
    • ¿Qué es CohRTA?
    • ¿Cómo funciona?
    • Centros CohRTA
    • Publicaciones e informes
  • Divulgación
    • Objetivos CohRTA
    • Una década de CohRTA
    • Hitos científicos del GIAS
    • Otros logros
  • Publicaciones
  • Colaboraciones
Seleccionar página
The relevance of personality traits in impulsivity-related disorders: From substance use disorders and gambling disorder to bulimia nervosa

The relevance of personality traits in impulsivity-related disorders: From substance use disorders and gambling disorder to bulimia nervosa

The relevance of personality traits in impulsivity-related disorders: From substance use disorders and gambling disorder to bulimia nervosa Autor: Del Pino-Gutiérrez A, Jiménez-Murcia S, Fernández-Aranda F, Agüera Z, Granero R, Hakansson A, et al. Revista: J Behav...
The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin

The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin

The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin Autor: Quintana P, Ventura M, Grifell M, Palma A, Galindo L, Fornís I, et al. Revista: Int J Drug Policy. 2017 Feb 1; 40:78–83. Fuente: sciencedirect.com Volver a...
Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder

Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder

Plasma concentrations of granulocyte colony-stimulating factor (G-CSF) in patients with substance use disorders and comorbid major depressive disorder Autor: Galván ST, Flores-López M, Romero-Sanchiz P, Requena-Ocaña N, Porras-Perales O, Nogueira-Arjona R, et al....
Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone)

Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone)

Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone) Autor: Grifell M, Ventura M, Carbón X, Quintana P, Galindo L, Palma Á, et al. Revista: Hum Psychopharmacol. 2017 May...
Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review Autor: Poyatos L, Pérez-Acevedo AP, Papaseit E, Pérez-Mañá C, Martin S, Hladun O, et al. Revista: Medicina (Kaunas). 2020 Jun 1; 56(6):1–28. Fuente: mdpi.com Volver a...
Optimal Use of Transient Elastography and Acoustic Radiation Force Impulse to Stage Liver Fibrosis in HIV/HCV-Coinfected Patients in Clinical Practice

Optimal Use of Transient Elastography and Acoustic Radiation Force Impulse to Stage Liver Fibrosis in HIV/HCV-Coinfected Patients in Clinical Practice

Optimal Use of Transient Elastography and Acoustic Radiation Force Impulse to Stage Liver Fibrosis in HIV/HCV-Coinfected Patients in Clinical Practice Autor: López JJ, Pérez-Àlvarez N, Rodríguez R V., Jou A, Carbonell P, Jiménez JA, et al. Revista: J Ultrasound Med....
« Entradas más antiguas
Entradas siguientes »

Buscar

Entradas por categoría

Entradas Recientes

  • ¿Es saludable el consumo moderado de alcohol? La evolución de la evidencia
  • Alcohol cero para personas con problemas de hígado
  • Ecografía abdominal para la valoración de daño hepático en pacientes con trastorno por uso de alcohol ingresados para tratamiento.
  • Pronóstico del síndrome Wernicke-Korsakoff asociado al alcohol. Estudio en una serie de casos diagnosticados entre 2002 y 2011.

Tweets by hugtipAdd

Somos un Grupo de Investigación Consolidado (2017 SGR 316; 2021 SGR 00945) por la Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) de la Generalitat de Cataluña.

Hospital_Universitari_Germans_Trias_i_Pujol

 

logo IGTP

  • Política de privacidad
  • Cookies
  • Contacto
  • X
GIAS. Grupo de Investigación en Adicciones a Sustancias // Desarrollo: La Doctora Álvarez